New drug combo targets tough pancreatic cancer in early trial
Disease control
Completed
This early-phase trial tested a new oral drug called IOA-289, alone and with standard chemotherapy, in 16 adults with metastatic pancreatic cancer that cannot be removed by surgery. The main goal was to check safety and find the right dose. Researchers also looked at how the drug…
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated May 15, 2026 11:56 UTC